Samalin Investment Counsel, LLC Sage Therapeutics, Inc. Transaction History

Samalin Investment Counsel, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$70.65 - $96.76 $7,065 - $9,676	-100 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$41.13 - $62.45 $4,113 - $6,245	100 New	100 $6,000
Q1 2020 May 04, 2020	SELL	$26.15 - $77.24 $6,537 - $19,310	-250 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$60.18 - $154.77 $15,045 - $38,692	250 New	250 $18,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $284M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.